Feature Channels: Pharmaceuticals

Filters close
Released: 30-Apr-2019 4:15 PM EDT
Diabetes Drug Could Help Smokers Kick the Habit
University of Texas Health Science Center at Houston

A diabetes drug is being enlisted in the war against smoking by UTHealth researchers.

29-Apr-2019 1:00 PM EDT
Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy
American Academy of Neurology (AAN)

Taking a pharmaceutical formulation of cannabidiol, a cannabis-based medicine, cut seizures nearly in half for children with a rare and severe type of epilepsy called Dravet syndrome, according to a phase 3 study released today that will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia, May 4 to 10, 2019. Dravet syndrome, which starts in infancy, can lead to intellectual disability and frequent, prolonged seizures. Cannabidiol is derived from marijuana that does not include the psychoactive part of the plant that creates a “high.”

Released: 30-Apr-2019 3:50 PM EDT
Fighting the Opioid Epidemic with New Knowledge: Univ. Of Michigan and Harvard Team Up for Opioid Summit
Michigan Medicine - University of Michigan

A day-long summit on opioid-related topics will focus on bringing findings from research and community-based efforts to those who can use them to make a difference in public policy and clinical practice.

   
Released: 30-Apr-2019 11:05 AM EDT
Nominations Now Open for 7th Annual Harrington Prize for Innovation in Medicine
University Hospitals Cleveland Medical Center

National and international nominations are being sought for the 2020 Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application.

Released: 30-Apr-2019 10:25 AM EDT
ASA Applauds CDC Acknowledgement of Misinterpretation of Opioid Prescribing Guideline
American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) is pleased with the Centers for Disease Control and Prevention (CDC) article published in the New England Journal of Medicine acknowledging problems with the agency’s Guideline for Prescribing Opioids for Chronic Pain. ASA has been a longtime advocate for the Guideline and was involved in its review and development in 2016.

Released: 29-Apr-2019 11:05 PM EDT
ASA Expresses Concern about ‘Medicare For All’
American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) continues to have serious concerns with the proposed “Medicare for All” legislation, which will be the subject of a hearing in the U.S. House of Representatives, Committee on Rules on Tuesday. The proposal would eliminate all private insurance and create a two-year transformation of Medicare into a nationwide, single-payer system, eliminating the age threshold for Medicare eligibility.

Released: 29-Apr-2019 1:00 PM EDT
Could Taking a Drug Within a Few Hours of a Trauma Help Avert Post Traumatic Stress Disorder?
Mount Sinai Health System

Mount Sinai Receives $6 Million Award from United States Department of Defense to Study Oral Hydrocortisone for PTSD Prevention

Released: 25-Apr-2019 3:05 PM EDT
Maternal-fetal medicine specialist first in US to lead clinical trial on life-threatening fetal blood disorder
University of Texas Health Science Center at Houston

An investigational drug that may block harmful antibodies from passing through the placenta of an expectant mother to the fetus is the focus of a new clinical trial led by Kenneth Moise, MD, a maternal-fetal medicine specialist at UTHealth.

24-Apr-2019 9:00 AM EDT
Study of Tagraxofusp Reports 90 Percent Response Rate for Deadly Blood Cancer with No Prior Available Therapies
University of Texas MD Anderson Cancer Center

An open-label, multi-cohort Phase II trial, led by investigators at The University of Texas MD Anderson Cancer Center, reports that treatment with the drug tagraxofusp resulted in high response rates in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare but highly aggressive – and often fatal bone marrow and blood disorder – for which there are no existing approved therapies.

Released: 24-Apr-2019 2:05 PM EDT
Bad Medicine? The Side Effects of Central Bank Mispricing
University of Virginia Darden School of Business

In response to the conditions produced by the 2007–09 financial crisis and the eurozone sovereign debt crisis that persisted, one of the world’s central banks doled out some strong medicine — and it caused considerable problems.

Released: 24-Apr-2019 11:30 AM EDT
New Synthesis Strategy Speeds Identification of Simpler Versions of a Natural Product
Baylor University

A new chemical synthesis strategy to harvest rich information found in natural products has led to identifying simpler derivatives with potential to selectively protect neurons -- important for such diseases as Alzheimer’s -- or to prevent the immune system from rejecting organ transplants.

18-Apr-2019 3:00 PM EDT
The Neurobiology of Noshing: Why is it so easy to overeat calorie-rich tasty foods?
University of North Carolina School of Medicine

Ever wonder why you really don’t want to stop eating delicious food even though you know you’ve eaten enough? UNC School of Medicine researchers may have found the reason – a specific cellular network motivated mice to keep eating tasty food even though their basic energy needs had been met.

   
Released: 23-Apr-2019 11:05 AM EDT
UIC and Deerfield Management launch West Loop Innovations to foster development of new therapeutics
University of Illinois Chicago

The University of Illinois at Chicago and Deerfield Management will establish West Loop Innovations, LLC to accelerate the commercialization of therapeutics developed at UIC. Deerfield will provide up to $65 million in translational research funding and commercialization expertise to advance promising UIC discoveries.

Released: 23-Apr-2019 10:05 AM EDT
Major Scientific Meeting on Sound Next Month in Louisville
Acoustical Society of America (ASA)

The Acoustical Society of America will hold its 177th meeting May 13-17 at the Galt House Hotel in Louisville, Kentucky. This major scientific conference brings together interdisciplinary groups of researchers from many far-flung fields, including physics, medicine, music, psychology, architecture and engineering, to discuss their latest research. It will feature nearly 1,000 presentations on sound and its applications

Released: 23-Apr-2019 8:05 AM EDT
Three-Antibiotic Cocktail Clears “Persister” Lyme Bacteria in Mouse Study
Johns Hopkins Bloomberg School of Public Health

A new study from researchers at the Johns Hopkins Bloomberg School of Public Health found that a slow-growing variant form of Lyme bacteria caused severe symptoms in a mouse model. The slow-growing variant form of Lyme bacteria, according to the researchers, may account for the persistent symptoms seen in ten to twenty percent of Lyme patients that are not cured by the current Lyme antibiotic treatment.

Released: 23-Apr-2019 7:05 AM EDT
Renowned Keynote and Plenary Speakers Will Debate Global Issues on the Future of HEOR at ISPOR 2019
ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR announced plenary sessions and speakers for ISPOR 2019. The conference will be held May 18-22, 2019 in New Orleans, LA, USA and will focus on the theme, “Rapid. Disruptive. Innovative: A New Era in Health Economics and Outcomes Research.”

Released: 23-Apr-2019 2:05 AM EDT
NUS researchers identified new biomarkers associated with ‘chemobrain’
National University of Singapore (NUS)

Researchers from the National University of Singapore have identified new biomarkers related to the cognitive impairment associated with cancer known as chemobrain.

Released: 19-Apr-2019 12:05 PM EDT
How Penicillin Acts Like TNT for Bacteria
Howard Hughes Medical Institute (HHMI)

Although penicillin was discovered nearly a century ago, scientists are still learning how the drug makes bacterial cells pop like overfilled balloons.

Released: 19-Apr-2019 11:05 AM EDT
People with Heart Disease at Risk When Pharmacies Close
University of Illinois Chicago

Research shows that when pharmacies close, people stop taking widely used heart medications — like statins, beta-blockers and oral anticoagulants — that have known cardiovascular and survival benefits. Declines in adherence — including the complete discontinuation of medication — were highest among people using independent pharmacies, filling all their prescriptions at a single store, or living in low-access neighborhoods with fewer pharmacies.

Released: 18-Apr-2019 12:05 PM EDT
Mount Sinai Researchers Discover That Diabetes Drug May Reverse Heart Failure
Mount Sinai Health System

Study finds drug could have new applications in non-diabetics

9-Apr-2019 3:05 PM EDT
Oxytocin could help treat alcohol use disorder
PLOS

The neuropeptide oxytocin blocks enhanced drinking in alcohol-dependent rats, according to a study published April 16 in the open-access journal PLOS Biology led by Drs. Tunstall, Koob and Vendruscolo of the National Institutes of Health

   
10-Apr-2019 12:05 PM EDT
Novel approach promises ready access to hard-to-study proteins
University of Wisconsin–Madison

A novel strategy capable of extracting and driving hard-to-reach proteins into water solution where they can be effectively studied using mass spectrometry promises a trove of biological insights and, importantly, may help identify therapeutically relevant proteins and provide new disease diagnostic techniques.

Released: 12-Apr-2019 9:00 AM EDT
Professors Team with Students to Transform Cell Growth, Drug Testing
Harrisburg University of Science and Technology

Dr. Leena Pattarkine and Dr. Shailaja Agrawal are partnering with students to design and fabricate a tool that will aid in the growth of cell cultures via a 3D platform. Launched this spring, the “Biopolymer Sponge Microfluidics for Continuous 3D Cell Culture and Drug Screening Project” aims to transform the field of drug screening and make it much more cost effective.

Released: 11-Apr-2019 8:05 AM EDT
Jay Goodman, PhD, and Janice B. Schwartz, MD, Receive PhRMA Foundation Award in Excellence
PhRMA Foundation

Noted researchers Jay Goodman, PhD, of Michigan State University and Janice B. Schwartz, MD, of the University of California, San Francisco, have received the PhRMA Foundation’s highest honor – its Award of Excellence – recognizing lifetime professional achievements.

Released: 10-Apr-2019 2:00 PM EDT
Southern Research teams with Ina Research to boost presence in Japan
Southern Research

Southern Research and Japan’s Ina Research announced today they have formed a partnership that calls for Ina to help connect Southern Research with potential new customers for drug development services in the country with the world’s third largest pharmaceutical industry.

   
Released: 10-Apr-2019 11:05 AM EDT
PhRMA Foundation Announces 2019 Pharmacology/Toxicology Grant and Fellowship Recipients
PhRMA Foundation

At the Annual Meeting of the American Society for Pharmacology and Experimental Therapeutics (ASPET) in Orlando this week, the PhRMA Foundation announced fourteen recipients of its 2019 grants and fellowships in pharmacology/toxicology.

Released: 9-Apr-2019 12:05 PM EDT
Novel study compares opioid deaths to treatment capacity by region to illustrate disadvantaged areas nationwide
University of Texas Health Science Center at Houston

Ohio, West Virginia, and the District of Columbia have the highest disparity between opioid-related deaths and access to treatment providers for opioid use disorder (OUD) in the U.S. That finding comes from a first-of-its-kind research study.

Released: 9-Apr-2019 9:00 AM EDT
As Doctor Shortage Continues, Residency Programs Show Some Success at Graduating More Primary Care Physicians
Johns Hopkins Medicine

Researchers at Johns Hopkins have found that how training is organized for doctors-in-training might impact their decision to go into primary care. The study, appearing online today in the Journal of General Internal Medicine suggests that a significant number of primary care internal medicine residents pursue careers in primary care, but perhaps could be more positively influenced if institutions paid more attention to how training is structured.

3-Apr-2019 10:05 AM EDT
Mount Sinai Researchers Develop Treatment That Turns Tumors Into Cancer Vaccine Factories
Mount Sinai Health System

Researchers at Mount Sinai have developed a novel approach to cancer immunotherapy, injecting immune stimulants directly into a tumor to teach the immune system to destroy it and other tumor cells throughout the body.

Released: 8-Apr-2019 9:00 AM EDT
SNMMI and ACR Collaborate on Clinical Data Registry for Nuclear Medicine
American College of Radiology (ACR)

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American College of Radiology (ACR) announce a new collaborative clinical data registry to support high-quality practice and patient care. The registry will allow collection and analysis of data on nuclear medicine procedures, supporting continuous improvement of patient care.

4-Apr-2019 1:05 PM EDT
Pediatric Telemedicine Visits May Increase Antibiotic Overprescribing
Health Sciences at the University of Pittsburgh

Children with acute respiratory infections were prescribed antibiotics more often during direct-to-consumer telemedicine visits than during in-person primary care appointments or urgent care visits, according to UPMC Children’s Hospital of Pittsburgh research reported today in Pediatrics.

2-Apr-2019 12:00 AM EDT
ASRA Names Dr. Jason Ochroch 2019 Resident/Fellow of the Year
American Society of Regional Anesthesia and Pain Medicine (ASRA)

The American Society of Regional Anesthesia and Pain Medicine (ASRA) has named Jason Ochroch, MD, a fellow at the University of Pennsylvania, the 2019 Resident/Fellow of the Year. The award is given annually to a resident or fellow member of ASRA who has demonstrated outstanding contributions to regional anesthesia or pain medicine; has contributed to the advancement of the profession, welfare of residents, or quality of residency education; serves as a role model and mentor to his or her peers; and embodies the values of ASRA.

2-Apr-2019 12:00 AM EDT
Best of Meeting Abstract: Peripheral Nerve Blockade Reduces Patient Opioid Use After Amputation Surgery
American Society of Regional Anesthesia and Pain Medicine (ASRA)

30-80% of amputee patients develop chronic pain after their surgery, and there is not yet a clear strategy for relieving that pain. Researchers found that adding liposomal bupivacaine to the nerve block in patients undergoing major lower extremity amputation helped reduce pain and opioid use.

2-Apr-2019 12:00 AM EDT
Joseph Neal to Receive Gaston Labat Award at ASRA Meeting in Las Vegas
American Society of Regional Anesthesia and Pain Medicine (ASRA)

Dr. Joseph M. Neal will receive ASRA’s 2019 Gaston Labat Award at the 44th Annual Regional Anesthesiology and Acute Pain Medicine Meeting in Las Vegas, NV. The Gaston Labat Award is given annually to an individual who has demonstrated outstanding contributions to the development, teaching, and practice of regional anesthesia in the tradition of Gaston P. Labat, MD (1843-1908).

2-Apr-2019 12:00 AM EDT
Best of Meeting Abstract: IV Acetaminophen Not Necessary for Minimally Invasive Spine Surgery
American Society of Regional Anesthesia and Pain Medicine (ASRA)

Although acetaminophen is frequently given prior to spine surgery to help reduce the need for opioids, this study found no benefit. Given the drug's high cost and low availability, researchers suggest it not be routinely given to this group of patients.

1-Apr-2019 9:00 AM EDT
Experimental Drug Shows Promise for Opioid Withdrawal Symptoms
Federation of American Societies for Experimental Biology (FASEB)

New findings suggest rapastinel could be useful to help manage withdrawal during the critical first days after someone has entered treatment and is trying to abstain from opioid use, according to researchers.

Released: 5-Apr-2019 11:05 AM EDT
Emergency department program aims at reducing opioid use disorder
University of Alabama at Birmingham

UAB launches an emergency room-based medication assisted treatment program, which includes providing peer navigators and certifying more physicians to prescribe Suboxone in an effort to corral the opioid crisis.

Released: 5-Apr-2019 8:05 AM EDT
ATS Foundation/Mallinckrodt Pharmaceuticals Research Fellowship in Sarcoidosis Awarded;
American Thoracic Society (ATS)

Landon W. Locke, PhD, of Ohio State University has been awarded the ATS Foundation/Mallinckrodt Pharmaceuticals Research Fellowship in Sarcoidosis. The $80,000 award will help fund Dr. Locke’s study, “Abnormally Sustained M2-like Macrophage Polarization Drives Sarcoidosis Granulomas.”

Released: 4-Apr-2019 2:05 PM EDT
ASA Supports Key Elements of HHS Pain Task Force Recommendations
American Society of Anesthesiologists (ASA)

In comments submitted to the federal government, the American Society of Anesthesiologists (ASA) formally supported the recommendations of the U.S. Department of Health and Human Services (HHS) Pain Management Best Practices Interagency Task Force.

Released: 4-Apr-2019 1:00 PM EDT
Using a promiscuous inhibitor to uncover cancer drug targets
American Society for Biochemistry and Molecular Biology (ASBMB)

Scientists at Harvard Medical School and the Dana-Farber Cancer Institute have developed a method that exploits the multitargeted nature of a chemical inhibitor to pinpoint vulnerabilities within cancer cells.

Released: 4-Apr-2019 9:00 AM EDT
Psychedelic Drug MDMA May Reawaken ‘Critical Period’ in Brain to Help Treat PTSD
Johns Hopkins Medicine

Johns Hopkins neuroscientists have found that the psychedelic drug MDMA reopens a kind of window, called a “critical period,” when the brain is sensitive to learning the reward value of social behaviors. The findings, reported April 3 in Nature, may explain why MDMA may be helpful in treating people with post-traumatic stress disorder (PTSD).

Released: 3-Apr-2019 10:05 AM EDT
New formula better predicts speed of tumor growth in 12 cancers
University at Buffalo

University at Buffalo researchers have developed a new method to more accurately predict tumor growth rates, a crucial statistic used to schedule screenings and set dosing regimens in cancer treatment.

Released: 3-Apr-2019 10:00 AM EDT
Southern Research taps April Brys to lead Drug Development division
Southern Research

Southern Research announced today that April M. Brys, Ph.D., an experienced life sciences executive with a strong track record in research and leadership roles, has been named vice president of the non-profit organization’s Drug Development division.

Released: 3-Apr-2019 9:00 AM EDT
Immunotherapy Kicks and Kills HIV by Exploiting a Common Virus
Health Sciences at the University of Pittsburgh

In a first on the quest to cure HIV, University of Pittsburgh scientists report that they’ve developed an all-in-one immunotherapy approach that not only kicks HIV out of hiding in the immune system, but also kills it. The key lies in immune cells designed to recognize an entirely different virus.

Released: 3-Apr-2019 12:00 AM EDT
Anesthesia Providers Convene to Discuss the 116th Congress, Regulatory and Legislative Solutions
American Association of Nurse Anesthesiology

This is the largest advocacy meeting for nurse anesthesia providers to focus in on the legislation that affects patients in need of anesthesia care and the practice of healthcare providers who administer the anesthesia.

Released: 2-Apr-2019 1:15 PM EDT
AACC Honors 2019 Award Winners for Advancing Laboratory Medicine and Patient Care
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2019 AACC and AACC Academy Awards. Through this annual awards program, AACC and its academy strive to recognize laboratory medicine professionals in all stages of their careers and to build public awareness that clinical laboratory testing plays a critical role in improving patient health.

Released: 2-Apr-2019 7:05 AM EDT
A "Low Dose Aspirin" for Dementia? Drug Ready for First in-Human Testing
University of Kentucky

Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. To date, there have been very few successes in the pursuit of a treatment. But one drug that looks at AD from a different angle is now ready for its first round of testing in humans.



close
2.61066